Subscribe to RSS
DOI: 10.1055/s-0044-1786041
Changing Nature of Endoleak in a Patient of Superior Mesenteric Artery Aneurysm Treated with Endovascular Stent Graft
Funding None.Abstract
A man in his early thirties with complaints of abdominal pain for 1 week was diagnosed with a fusiform, partially thrombosed aneurysm of the superior mesenteric artery (SMA), which was treated with an endovascular stent graft. Three months later, when the patient again presented with abdominal pain, there was an endoleak of type III as detected by computed tomography and digital subtraction angiography. This was treated by in-stent balloon angioplasty with complete resolution of the endoleak. The patient again presented 1 month later with abdominal pain, with a residual sac posterior to the stent, detected on digital subtraction angiography, which was confirmed to be type II endoleak as it was getting filled by one of the jejunal branches of SMA. This was treated by glue embolization of the patent component of the aneurysm after selectively cannulating the branch vessel. This case highlights changing nature of endoleak as a complication of SMA stenting.
IRB Approval, Consent Statement and Clinical Trial Registration
The Institutional Ethics Committee waived off the need for patient written informed consent.
Data Availability Statement
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Publication History
Article published online:
19 April 2024
© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 Stone WM, Abbas M, Cherry KJ, Fowl RJ, Gloviczki P. Superior mesenteric artery aneurysms: is presence an indication for intervention?. J Vasc Surg 2002; 36 (02) 234-237 , discussion 237
- 2 Jiang J, Ding X, Su Q. et al. Therapeutic management of superior mesenteric artery aneurysms. J Vasc Surg 2011; 53 (06) 1619-1624
- 3 Zilun L, Henghui Y, Yang Z, Mian W, Guangqi C, Shenming W. The management of superior mesenteric artery aneurysm: experience with 16 cases in a single center. Ann Vasc Surg 2017; 42: 120-127
- 4 McGraw JK, Patzik SB, Gale SS, Dodd JT, Boorstein JM. Autogenous vein-covered stent for the endovascular management of a superior mesenteric artery pseudoaneurysm. J Vasc Interv Radiol 1998; 9 (05) 779-782
- 5 Mendonça CT, Weingartner J, de Carvalho CA, Costa DS. Endovascular treatment of contained rupture of a superior mesenteric artery aneurysm resulting from neurofibromatosis type I. J Vasc Surg 2010; 51 (02) 461-464
- 6 Jimenez JC, Lawrence PF, Reil TD. Endovascular exclusion of superior mesenteric artery pseudoaneurysms: an alternative to open laparotomy in high-risk patients. Vasc Endovascular Surg 2008; 42 (02) 184-186
- 7 Appel N, Duncan JR, Schuerer DJ. Percutaneous stent-graft treatment of superior mesenteric and internal iliac artery pseudoaneurysms. J Vasc Interv Radiol 2003; 14 (07) 917-922